TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15466963

Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 56
Study: 11673752

Group type: EXPERIMENTAL
Intervention: Losartan 50 mg/d
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 10211063

Group type: EXPERIMENTAL
Intervention: Short axis imaging with echo time of 14 ms and flip angle of 45 degrees at rest
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Short axis imaging with echo time of 14 ms and flip angle of 45 degrees during stress
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Long axis imaging at end-diastole
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Increasing echo time and flip angle
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Short axis plane imaging
Number of subjects: 2
Study: 3289769

Group type: EXPERIMENTAL
Intervention: Patient-Controlled Epidural Analgesia (PCEA) - Group A (n = 14) received a background infusion of 4 ml/hr 0.125% bupivacaine, with self-administered 4 ml aliquots as required (up to 16 ml/hr).
Number of subjects: 27

Group type: COMPARATOR
Intervention: Continuous Infusion Epidural Analgesia (CIEA) - Group B (n = 11) received a continuous infusion of 12 ml/hr with the demand-button deactivated.
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Patient-Controlled Epidural Analgesia (PCEA) - Group A (n = 14).
Number of subjects: 27
Study: 30954071

Group type: EXPERIMENTAL
Intervention: RIPC+RIPostC
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control
Number of subjects: 120
Study: 27794035

Group type: EXPERIMENTAL
Intervention: Benign metaphor
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Gambling metaphor
Number of subjects: 500

Group type: COMPARATOR
Intervention: Plain language
Number of subjects: 500

Group type: COMPARATOR
Intervention: Control message
Number of subjects: 500
Study: 25593485

Group type: EXPERIMENTAL
Intervention: Increased physical activity
Number of subjects: 39
Study: 23553790

Group type: EXPERIMENTAL
Intervention: Tanezumab 2.5 mg
Number of subjects: 621

Group type: EXPERIMENTAL
Intervention: Tanezumab 5 mg
Number of subjects: 621

Group type: EXPERIMENTAL
Intervention: Tanezumab 10 mg
Number of subjects: 621

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 621
Study: 21938889

Group type: EXPERIMENTAL
Intervention: Therapeutic Instrumental Music Performance (TIMP)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Traditional Occupational Therapy (TOT)
Number of subjects: 35
Study: 18842610

Group type: EXPERIMENTAL
Intervention: Prophylactic probiotics
Number of subjects: 0
Study: 17122578

Group type: EXPERIMENTAL
Intervention: 250 ml Hemospan
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 500 ml Hemospan
Number of subjects: 90

Group type: COMPARATOR
Intervention: Ringer's acetate (Control)
Number of subjects: 90
Study: 15322325

Group type: EXPERIMENTAL
Intervention: Combined formula consisting of ACEI, AIIRA, CCB, antiplatelet+/−heparin
Number of subjects: 18
Study: 10585174

Group type: EXPERIMENTAL
Intervention: Norethisterone acetate (NETA; 0.5 mg) alone
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Norethisterone acetate (NETA; 0.5 mg) in combination with estradiol (E2; 1 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Combination of 0.5 mg NETA with 1 mg E2 administered daily for 28 days
Number of subjects: 24
Study: 8901825

Group type: EXPERIMENTAL
Intervention: Ramipril and felodipine treatment for 6 months
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Drug washout after treatment
Number of subjects: 100
Study: 2053167

Group type: EXPERIMENTAL
Intervention: EPO therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High EPO group
Number of subjects: 0
Study: 6660046

Group type: EXPERIMENTAL
Intervention: atenolol (n = 9)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: oxprenolol (n = 10)
Number of subjects: 19
Study: 31578205

Group type: EXPERIMENTAL
Intervention: Ruxolitinib (RUX)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Best Available Therapy (BAT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Presence of non-MPN driver mutations (NDM)
Number of subjects: 0
Study: 29743106

Group type: EXPERIMENTAL
Intervention: Hysterosalpingo-foam sonography (HyFoSy)
Number of subjects: 1163

Group type: COMPARATOR
Intervention: Hysterosalpingography (HSG)
Number of subjects: 1163

Group type: EXPERIMENTAL
Intervention: HyFoSy
Number of subjects: 1163

Group type: COMPARATOR
Intervention: HSG
Number of subjects: 1163
Study: 27310880

Group type: EXPERIMENTAL
Intervention: Cornisol
Number of subjects: 32

Group type: COMPARATOR
Intervention: Optisol‐GS
Number of subjects: 32
Study: 24226309

Group type: EXPERIMENTAL
Intervention: Telephone-based motivational interviewing (MI)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Healthy activity living guide (information only control)
Number of subjects: 86
Study: 22855138

Group type: EXPERIMENTAL
Intervention: TOMOX
Number of subjects: 191

Group type: COMPARATOR
Intervention: FOLFOX4
Number of subjects: 191
Study: 20695361

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 18235123

Group type: EXPERIMENTAL
Intervention: Addition of muramyl tripeptide (MTP) to chemotherapy
Number of subjects: 662

Group type: COMPARATOR
Intervention: Chemotherapy without MTP
Number of subjects: 662

Group type: COMPARATOR
Intervention: Addition of ifosfamide to chemotherapy
Number of subjects: 662
Study: 15722905

Group type: EXPERIMENTAL
Intervention: (99m)Tc LeukoScan SPECT at 4 h
Number of subjects: 22

Group type: COMPARATOR
Intervention: (99m)Tc HMPAO labelled white cell imaging
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: LeukoScan planar images at 2 h
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: LeukoScan planar images at 4 h
Number of subjects: 22
Study: 12849765

Group type: EXPERIMENTAL
Intervention: Right frontal lesions group (patients with right frontal lesions)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Left frontal lesions group (patients with left frontal lesions)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Right frontal lesions group
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Left frontal lesions group and right frontal lesions group
Number of subjects: 67
Study: 10374198

Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group (not receiving thrombolytic agents)
Number of subjects: 8
Study: 8911009

Group type: EXPERIMENTAL
Intervention: Jet injector
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Intramuscular (i.m.)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Subcutaneous (s.c.)
Number of subjects: 147
Study: 1846723

Group type: EXPERIMENTAL
Intervention: Instant oats (2 servings per day, approximately two ounces dry weight)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no oats)
Number of subjects: 0
Study: 6344914

Group type: EXPERIMENTAL
Intervention: Early elective splenectomy
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Prognostic features
Number of subjects: 169
Study: 31925799

Group type: EXPERIMENTAL
Intervention: Tibolone 2.5 mg daily
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Continuous oral oestradiol-17β 2 mg plus norethisterone acetate 1 mg daily (E2/NETA)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study: 31263933

Group type: EXPERIMENTAL
Intervention: Sub mucosal partial inferior turbinectomy
Number of subjects: 110

Group type: COMPARATOR
Intervention: Out fracture of inferior turbinate
Number of subjects: 110
Study: 29453467

Group type: COMPARATOR
Intervention: Standard dose magnesium sulfate
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Loading dose only magnesium sulfate
Number of subjects: 60
Study: 26795675

Group type: EXPERIMENTAL
Intervention: iPad with access to the personalized inpatient portal
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: iPad with general internet access
Number of subjects: 426

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 426
Study: 24647513

Group type: EXPERIMENTAL
Intervention: Internal fixation with two screws (n = 78)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Cemented total hip replacement (n = 68)
Number of subjects: 143
Study: 21600848

Group type: EXPERIMENTAL
Intervention: CD recording of consultation (n=10)
Number of subjects: 17

Group type: COMPARATOR
Intervention: No CD (Control group, n=7)
Number of subjects: 17
Study: 20726625

Group type: EXPERIMENTAL
Intervention: SABA (short-acting beta-agonists)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Leukotriene receptor antagonists (LTRA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mast cell stabilizers (MCS) (nedocromil sodium)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interval warmup
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids (ICS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Continuous low intensity warmup
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Continuous high intensity warmup
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Daily LABA (salmeterol)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Daily SABA
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mast cell stabilizers (MCS) plus SABA
Number of subjects: 0
Study: 18029469

Group type: EXPERIMENTAL
Intervention: 10 mg/d rosuvastatin
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 40 mg/d rosuvastatin
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 15967175

Group type: EXPERIMENTAL
Intervention: Angry participants
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Angry and anxious participants
Number of subjects: 84
Study: 11850709

Group type: EXPERIMENTAL
Intervention: Blood Cell (BC) collection
Number of subjects: 64

Group type: COMPARATOR
Intervention: Bone Marrow (BM) collection
Number of subjects: 64
Study: 10613433

Group type: EXPERIMENTAL
Intervention: Aerobic fitness measured by VO2max
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Aerobic fitness measured by T(VE)
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: VO2max relative to body mass
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Minimum level of aerobic power compatible with independent life
Number of subjects: 298
Study: 7907950

Group type: EXPERIMENTAL
Intervention: Taxotere (docetaxel) intravenous infusion at doses of 70-115 mg/m2 every 3 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Taxotere (docetaxel) intravenous infusion
Number of subjects: 0
Study: 3002163

Group type: EXPERIMENTAL
Intervention: High fiber diet (27 g/1000 kcal)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal fiber diet (11 g/1000 kcal)
Number of subjects: 0
Study: 30188014

Group type: EXPERIMENTAL
Intervention: RUSleeping® (portable monitoring device)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Polysomnography (PSG)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Epworth Sleepiness Scale
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Simple questionnaire
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Mean apnea-hypopnoea index (AHI)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Multivariate logistic regression analysis
Number of subjects: 114
Study: 26539650

Group type: EXPERIMENTAL
Intervention: rosuvastatin 10 mg
Number of subjects: 1146

Group type: EXPERIMENTAL
Intervention: atorvastatin 10 mg
Number of subjects: 1146

Group type: EXPERIMENTAL
Intervention: simvastatin 20 mg
Number of subjects: 1146

Group type: EXPERIMENTAL
Intervention: pravastatin 40 mg
Number of subjects: 1146

Group type: EXPERIMENTAL
Intervention: rosuvastatin 20 mg
Number of subjects: 1146

Group type: EXPERIMENTAL
Intervention: rosuvastatin 40 mg
Number of subjects: 1146

Group type: EXPERIMENTAL
Intervention: atorvastatin 40 mg
Number of subjects: 1146

Group type: EXPERIMENTAL
Intervention: atorvastatin 80 mg
Number of subjects: 1146

Group type: EXPERIMENTAL
Intervention: rosuvastatin (all doses)
Number of subjects: 1146

Group type: COMPARATOR
Intervention: All treatments
Number of subjects: 1146
Study: 26180214

Group type: EXPERIMENTAL
Intervention: Graphic warning labels (GWLs)
Number of subjects: 4436

Group type: COMPARATOR
Intervention: Text-only warning labels (control)
Number of subjects: 4436
Study: 23442391

Group type: EXPERIMENTAL
Intervention: Probiotics capsules containing > 1x10(9) cfu each of Lactobacillus rhamnosus GG and Bifidobacterium lactis BB‐12 per capsule, administered from 16 weeks gestation until delivery.
Number of subjects: 540

Group type: COMPARATOR
Intervention: Placebo capsules, administered from 16 weeks gestation until delivery.
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 540

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 540
Study: 20852880

Group type: EXPERIMENTAL
Intervention: Eccentric exercise of elbow flexors (EF)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Eccentric exercise of elbow extensors (EE)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Eccentric exercise of knee flexors (KF)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Eccentric exercise of knee extensors (KE)
Number of subjects: 17
Study: 19114190

Group type: EXPERIMENTAL
Intervention: Special acupuncture technique (preoperative implantation of small intradermal needles retained for 4 weeks)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Sham acupuncture technique (preoperative placement of sham needles)
Number of subjects: 162
Study: 17136231

Group type: EXPERIMENTAL
Intervention: Prophylactic administration of ibuprofen on the first day of life
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Therapeutic administration of ibuprofen to induce closure of a symptomatic PDA
Number of subjects: 0
Study: 12600800

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 1350

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS) with strong, subnoxious electrical stimulation
Number of subjects: 1350

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS) without explicit confirmation of sufficient current intensity and adequate frequency
Number of subjects: 1350

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1350
Study: 11144434

Group type: EXPERIMENTAL
Intervention: BF-supplemented WHO ORS
Number of subjects: 150

Group type: COMPARATOR
Intervention: WHO ORS
Number of subjects: 150
Study: 9547777

Group type: EXPERIMENTAL
Intervention: 5.2-mm incision
Number of subjects: 50

Group type: COMPARATOR
Intervention: 3.5-mm incision
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study: 7826833

Group type: EXPERIMENTAL
Intervention: High dose metoclopramide (7 mg kg‐1 day‐1)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Alizapride (5 mg kg‐1 day‐1)
Number of subjects: 32
Study: 3059898

Group type: EXPERIMENTAL
Intervention: poncho wrap, negative-pressure ventilator
Number of subjects: 20

Group type: COMPARATOR
Intervention: standard care
Number of subjects: 20
Study: 29937115

Group type: EXPERIMENTAL
Intervention: Keep It Up! intervention
Number of subjects: 901

Group type: COMPARATOR
Intervention: Control condition (existing online HIV information)
Number of subjects: 901
Study: 27860292

Group type: EXPERIMENTAL
Intervention: Self-monitoring through frequent interviews
Number of subjects: 145

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 145
Study: 26197707

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) 400 mg/day
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 23568575

Group type: EXPERIMENTAL
Intervention: Donepezil (10 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Scopolamine (0.6 mg)
Number of subjects: 0
Study: 21926189

Group type: EXPERIMENTAL
Intervention: Tailored cognitive-behavioural therapy and exercise training (16 twice-weekly sessions)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting list control group (WLC)
Number of subjects: 0
Study: 19033840

Group type: EXPERIMENTAL
Intervention: Radiofrequency incision
Number of subjects: 23

Group type: COMPARATOR
Intervention: Scalpel incision
Number of subjects: 23
Study: 17209739

Group type: EXPERIMENTAL
Intervention: Masking the upper half of the face
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Masking the lower half of the face
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Masking the eye region
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Masking the mouth region
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Combination of kinship information from two halves of the face
Number of subjects: 220
Study: 12850126

Group type: EXPERIMENTAL
Intervention: Levodropropizine 6% drops administered orally t.i.d. for 10 consecutive administrations
Number of subjects: 24
Study: 11000359

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 17

Group type: COMPARATOR
Intervention: Conventional surgery
Number of subjects: 17
Study: 8616085

Group type: EXPERIMENTAL
Intervention: Bone marrow transplantation from partially HLA-mismatched related donors
Number of subjects: 52

Group type: COMPARATOR
Intervention: Bone marrow transplantation from HLA-identical siblings
Number of subjects: 52
Study: 1555693

Group type: EXPERIMENTAL
Intervention: Short regimen of gonadotropin-releasing hormone agonist
Number of subjects: 87

Group type: COMPARATOR
Intervention: Long regimen of gonadotropin-releasing hormone agonist
Number of subjects: 87
Study: 2580288

Group type: EXPERIMENTAL
Intervention: Vitreous carbon tip leads
Number of subjects: 150

Group type: COMPARATOR
Intervention: Elgiloy tip leads
Number of subjects: 150
Study: 31779992

Group type: EXPERIMENTAL
Intervention: Shotblocker
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no Shotblocker)
Number of subjects: 0
Study: 29397091

Group type: EXPERIMENTAL
Intervention: Herbal steam bath
Number of subjects: 64

Group type: COMPARATOR
Intervention: Steam bath without herbs
Number of subjects: 64
Study: 27449274

Group type: EXPERIMENTAL
Intervention: Abstinence intervention
Number of subjects: 1462
Study: 25194505

Group type: EXPERIMENTAL
Intervention: Mobile 3D viewing
Number of subjects: 26
Study: 22370698

Group type: EXPERIMENTAL
Intervention: 3 mg oral melatonin daily for 4 months
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study: 20822027

Group type: EXPERIMENTAL
Intervention: Qingfeihuayu soup, two times a day
Number of subjects: 82

Group type: COMPARATOR
Intervention: Rocephin 2 g once daily for 7 days
Number of subjects: 82
Study: 17400756

Group type: EXPERIMENTAL
Intervention: Cutting PTA
Number of subjects: 114

Group type: COMPARATOR
Intervention: Conventional PTA
Number of subjects: 114
Study: 15625610

Group type: EXPERIMENTAL
Intervention: Stone Cone
Number of subjects: 56

Group type: COMPARATOR
Intervention: Standard flat wire basket
Number of subjects: 56
Study: 12394728

Group type: EXPERIMENTAL
Intervention: Blinded review
Number of subjects: 234

Group type: COMPARATOR
Intervention: Unblinded review
Number of subjects: 234
Study: 10430393

Group type: EXPERIMENTAL
Intervention: Hypoxic upper abdominal chemotherapy (Mitomycin‐C, 5‐Fluorouracil, Leucovorin, Farmorubicin) plus systemic chemotherapy
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Hypoxic upper abdominal chemotherapy (Mitomycin‐C, 5‐Fluorouracil, Leucovorin, Farmorubicin) without systemic chemotherapy
Number of subjects: 58

Group type: COMPARATOR
Intervention: No neo or adjuvant treatment
Number of subjects: 58
Study: 7571220

Group type: EXPERIMENTAL
Intervention: Doxazosin 4 mg/day for 3 months (after a 3-week titration period)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Doxazosin 8 mg/day for 3 months (after a 3-week titration period)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Doxazosin administered in the morning or evening
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Adverse events (dizziness in 5 patients, fatigue in 4)
Number of subjects: 63
Study: 2076734

Group type: EXPERIMENTAL
Intervention: Co-dergocrine mesylate (Cod) 4 mg followed by Nifedipine (Nif) 20 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Nifedipine (Nif) 20 mg with placebo as premedication
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Nifedipine (Nif) 20 mg with Cod as premedication
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Nifedipine (Nif) 20 mg
Number of subjects: 18
Study: 495541

Group type: EXPERIMENTAL
Intervention: Thiamin intake of 0.30 mg per 1000 kcal (derived from carbohydrate sources)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thiamin intake of 0.40 mg per 1000 kcal (recommended by FAO/WHO)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thiamin intake of 0.5 mg per 1000 kcal (recommended by Food and Nutrition Board of NAS‐NRC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Erythrocyte transketolase activity and urinary excretion of thiamin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Microbiological assay (Lactobacillus viridescens) for measuring thiamin levels in urine
Number of subjects: 0
Study: 31349906

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided PIV placement with guidewire
Number of subjects: 69

Group type: COMPARATOR
Intervention: Ultrasound-guided PIV placement without guidewire
Number of subjects: 69
Study: 31480045

Group type: EXPERIMENTAL
Intervention: Pantoprazole (intravenously once daily during ICU stay, until ICU discharge, death, or a maximum of 90 days)
Number of subjects: 3291

Group type: COMPARATOR
Intervention: Placebo (intravenously once daily during ICU stay, until ICU discharge, death, or a maximum of 90 days)
Number of subjects: 3291
Study: 28538380

Group type: EXPERIMENTAL
Intervention: Cinacalcet (30 mg)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 25844682

Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser irradiation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (same laser without laser emission)
Number of subjects: 30
Study: 23457307

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX) for 6 months
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 56
Study: 21879181

Group type: EXPERIMENTAL
Intervention: Rectal ozone therapy
Number of subjects: 64

Group type: COMPARATOR
Intervention: Rectal medicinal oxygen
Number of subjects: 64

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 64
Study: 19453516

Group type: EXPERIMENTAL
Intervention: Acute psychological stress (IQ test)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control task
Number of subjects: 25